Key Insights

Highlights

Success Rate

86% trial completion

Published Results

229 trials with published results (21%)

Research Maturity

697 completed trials (65% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

10.2%

110 terminated out of 1076 trials

Success Rate

86.4%

-0.2% vs benchmark

Late-Stage Pipeline

33%

352 trials in Phase 3/4

Results Transparency

33%

229 of 697 completed with results

Key Signals

229 with results86% success110 terminated

Data Visualizations

Phase Distribution

852Total
Not Applicable (250)
Early P 1 (5)
P 1 (57)
P 2 (188)
P 3 (222)
P 4 (130)

Trial Status

Completed697
Unknown110
Terminated110
Recruiting59
Withdrawn37
Not Yet Recruiting36

Trial Success Rate

86.4%

Benchmark: 86.6%

Based on 697 completed trials

Clinical Trials (1076)

Showing 20 of 20 trials
NCT01665378Not ApplicableCompletedPrimary

Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child Outcomes

NCT07855458Not Yet Recruiting

ESA Hyporesponsiveness in Hemodialysis Patients

NCT07738510Phase 2Not Yet Recruiting

A Study to Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions

NCT07623161Phase 3Recruiting

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

NCT04455841Phase 1CompletedPrimary

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

NCT00843882Phase 3Active Not RecruitingPrimary

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

NCT07368972Phase 2Recruiting

Study of DISC-0974-201 in Participants With IBD and Anemia

NCT05320198Phase 1Recruiting

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT03459287Phase 3CompletedPrimary

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

NCT07832526Not ApplicableNot Yet RecruitingPrimary

Menstruation and Anemia Research: A Community Health Study

NCT03558464Not ApplicableCompleted

Effectiveness Study During the First 1,000 Days in Kenya

NCT07493772Not ApplicableNot Yet RecruitingPrimary

Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania

NCT07422480Phase 3Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT05699005Phase 1Recruiting

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO

NCT07381426Phase 3RecruitingPrimary

Ferric Citrate in Iron Deficiency Anemia During Pregnancy

NCT07814378Not Yet RecruitingPrimary

Impact of Iron Supplementation During Pregnancy

NCT05664737Phase 2Active Not RecruitingPrimary

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

NCT06637137RecruitingPrimary

Patient Blood Management in Patients Scheduled for Cardiac Surgery

NCT05889052CompletedPrimary

Perennial Malaria Chemoprevention (PMC) in Cameroon

NCT05856357Completed

Perennial Malaria Chemoprevention (PMC) in Côte d'Ivoire

Scroll to load more

Research Network

Activity Timeline